FBLG Stock Price | FibroBiologics, Inc. Common Stock P/E, Revenue, EPS, & Forecasts

FibroBiologics, Inc. Common Stock • FBLG

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About FibroBiologics, Inc. Common Stock

Ticker

FBLG

Trading on

NASDAQ

ISIN

US31573L1052

Industry

Biotechnology

Sector

Healthcare

CEO

Peter O'Heeron

Headquarters

455 East Medical Center Boulevard, Houston, TX, United States, 77598

Employees

Website

https://fibrobiologics.com

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

Metrics

BasicAdvanced

Market cap

$27.9M

P/E ratio

EPS

-$0.48

Dividend Yield

0.00%

Beta

-0.67

Forward P/E ratio

EBIDTA

$-16.4M

Ex dividend date

Price & volume

Market cap

$27.9M

Average daily volume

1.3M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

174.87

Earnings

EPS

-$0.48

EPS estimate (current quarter)

-$0.10

EPS estimate (next quarter)

-$0.10

EBITDA

$-16.4M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

-0.67

52-week High

$1.53

52-week Low

$0.22

50-day moving average

$0.29

200-day moving average

$0.50

Short ratio

0.6

Short %

1.04%

Management effectiveness

ROE (TTM)

-419.44%

ROA (TTM)

-79.85%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

66.5M

Float

55.7M

Insiders %

17.60%

Institutions %

6.54%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 3 analysts.

Average price target

$4.75

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.14

-$0.13

-12.00%

Q1 • 25Missed

-$0.12

Q2 • 25Beat

-$0.13

-$0.12

-13.04%

Q3 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-5.8M

-∞%

Q3 • 25

$0M

$-3.2M

-∞%

Q4 • 25

NaN%

-43.86%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$8.7M

$8.6M

98.57%

Q3 • 25

$9.6M

$3.5M

36.00%

Q4 • 25

10.01%

-59.82%

-63.48%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-4M

$-0M

$0M

$-4M

Q3 • 25

$-3.2M

$3.2M

$-3.2M

Q4 • 25

-20.37%

∞%

-20.49%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a FibroBiologics, Inc. Common Stock share?

FibroBiologics, Inc. Common Stock shares are currently traded for undefined per share.

How many shares does FibroBiologics, Inc. Common Stock have?

FibroBiologics, Inc. Common Stock currently has 66.5M shares.

Does FibroBiologics, Inc. Common Stock pay dividends?

No, FibroBiologics, Inc. Common Stock doesn't pay dividends.

What is FibroBiologics, Inc. Common Stock 52 week high?

FibroBiologics, Inc. Common Stock 52 week high is $1.53.

What is FibroBiologics, Inc. Common Stock 52 week low?

FibroBiologics, Inc. Common Stock 52 week low is $0.22.

What is the 200-day moving average of FibroBiologics, Inc. Common Stock?

FibroBiologics, Inc. Common Stock 200-day moving average is $0.50.

Who is FibroBiologics, Inc. Common Stock CEO?

The CEO of FibroBiologics, Inc. Common Stock is Peter O'Heeron.

How many employees FibroBiologics, Inc. Common Stock has?

FibroBiologics, Inc. Common Stock has 15 employees.

What is the market cap of FibroBiologics, Inc. Common Stock?

The market cap of FibroBiologics, Inc. Common Stock is $27.9M.

What is the P/E of FibroBiologics, Inc. Common Stock?

The current P/E of FibroBiologics, Inc. Common Stock is null.

What is the EPS of FibroBiologics, Inc. Common Stock?

The EPS of FibroBiologics, Inc. Common Stock is -$0.48.

What is the PEG Ratio of FibroBiologics, Inc. Common Stock?

The PEG Ratio of FibroBiologics, Inc. Common Stock is null.

What do analysts say about FibroBiologics, Inc. Common Stock?

According to the analysts FibroBiologics, Inc. Common Stock is considered a buy.